ES547871A0 - Metodo para producir la proteina factor recombinante de necrosis de tumores hermanos (tnf) a partir de celulas hospedantes competentes transformadas con un vector de expresion. - Google Patents

Metodo para producir la proteina factor recombinante de necrosis de tumores hermanos (tnf) a partir de celulas hospedantes competentes transformadas con un vector de expresion.

Info

Publication number
ES547871A0
ES547871A0 ES547871A ES547871A ES547871A0 ES 547871 A0 ES547871 A0 ES 547871A0 ES 547871 A ES547871 A ES 547871A ES 547871 A ES547871 A ES 547871A ES 547871 A0 ES547871 A0 ES 547871A0
Authority
ES
Spain
Prior art keywords
hospedant
brother
competent
tnf
produce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES547871A
Other languages
English (en)
Other versions
ES8704547A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/730,696 external-priority patent/US4677064A/en
Priority claimed from US06/760,661 external-priority patent/US4677063A/en
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of ES547871A0 publication Critical patent/ES547871A0/es
Publication of ES8704547A1 publication Critical patent/ES8704547A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ES547871A 1984-10-15 1985-10-15 Metodo para producir la proteina factor recombinante de necrosis de tumores hermanos (tnf) a partir de celulas hospedantes competentes transformadas con un vector de expresion. Expired ES8704547A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66102684A 1984-10-15 1984-10-15
US67036084A 1984-11-09 1984-11-09
US06/730,696 US4677064A (en) 1984-11-09 1985-05-02 Human tumor necrosis factor
US06/760,661 US4677063A (en) 1985-05-02 1985-07-30 Human tumor necrosis factor

Publications (2)

Publication Number Publication Date
ES547871A0 true ES547871A0 (es) 1987-04-01
ES8704547A1 ES8704547A1 (es) 1987-04-01

Family

ID=27505306

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547871A Expired ES8704547A1 (es) 1984-10-15 1985-10-15 Metodo para producir la proteina factor recombinante de necrosis de tumores hermanos (tnf) a partir de celulas hospedantes competentes transformadas con un vector de expresion.

Country Status (11)

Country Link
EP (1) EP0200748B1 (es)
JP (1) JPH0866194A (es)
AU (1) AU589919B2 (es)
BG (1) BG60238B1 (es)
DE (1) DE3581730D1 (es)
DK (1) DK279886A (es)
ES (1) ES8704547A1 (es)
FI (1) FI862531A (es)
IL (1) IL76699A (es)
NO (1) NO174970C (es)
WO (1) WO1986002381A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3582183D1 (de) * 1984-03-06 1991-04-25 Dainippon Pharmaceutical Co Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid.
US5288852A (en) * 1984-03-06 1994-02-22 Dainippon Pharmaceutical Co., Ltd. Human tumor necrosis factor polypeptides
JPS6248634A (ja) * 1985-07-23 1987-03-03 Mochida Pharmaceut Co Ltd 新規アミノ酸組成物、その製造方法及び該アミノ酸組成物を含有する医療組成物
CA1286843C (en) * 1985-10-30 1991-07-23 Leo S. Lin Purification method for proteins
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
DE3750056T2 (de) * 1986-06-20 1995-04-06 Dainippon Pharmaceutical Co Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS.
FR2601678B1 (fr) * 1986-07-18 1989-11-24 Inst Nat Sante Rech Med Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie
WO1988006625A2 (en) * 1987-02-26 1988-09-07 Cetus Corporation Arginine-depleted human tumor necrosis factor
DE3837012A1 (de) * 1988-01-15 1989-07-27 Knoll Ag Verwendung von tnf und lt zur herstellung von arzneimitteln
JPH0797997B2 (ja) * 1988-04-28 1995-10-25 帝人株式会社 新規生理活性ポリペプチド
DE3841754A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
DE3841768A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
DE3841764A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
DE3843534A1 (de) * 1988-12-23 1990-07-12 Basf Ag Neue tnf-polypeptide
GB8905606D0 (en) * 1989-03-11 1989-04-26 Scras Peptides
JP2930713B2 (ja) 1989-08-16 1999-08-03 カイロン コーポレイション タンパク質ホルモン形成の抑制用の組成物およびその使用法
JP3203599B2 (ja) * 1989-10-24 2001-08-27 カイロン コーポレイション 感染性タンパク質デリバリーシステム
EP3936137A1 (en) 2013-02-07 2022-01-12 The General Hospital Corporation Methods for expansion or depletion of t-regulatory cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90047A (en) * 1982-10-19 1992-12-01 Cetus Oncology Corp Cysteine-depleted biologically active muteins other than interferon - '
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
DE3472793D1 (en) * 1983-12-26 1988-08-25 Asahi Chemical Ind A novel physiologically active polypeptide
DE3582183D1 (de) * 1984-03-06 1991-04-25 Dainippon Pharmaceutical Co Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid.
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
DE3517153A1 (de) * 1985-01-07 1986-07-10 Murillo Contreras, Jesús, México Feuerhemmende beschichtungsmischung und verfahren zu deren herstellung
JP2515975B2 (ja) * 1985-02-26 1996-07-10 大日本製薬株式会社 抗腫瘍作用を有するポリペプチド

Also Published As

Publication number Publication date
DK279886D0 (da) 1986-06-13
IL76699A (en) 1998-03-10
JPH0866194A (ja) 1996-03-12
EP0200748B1 (en) 1991-02-06
NO862353D0 (no) 1986-06-12
FI862531A0 (fi) 1986-06-13
AU5010685A (en) 1986-05-02
NO174970B (no) 1994-05-02
BG60238B1 (bg) 1994-01-24
DE3581730D1 (de) 1991-03-14
BG60238B2 (bg) 1994-01-18
WO1986002381A1 (en) 1986-04-24
NO174970C (no) 1994-08-10
FI862531A (fi) 1986-06-13
AU589919B2 (en) 1989-10-26
EP0200748A1 (en) 1986-11-12
DK279886A (da) 1986-06-13
IL76699A0 (en) 1986-02-28
NO862353L (no) 1986-06-12
ES8704547A1 (es) 1987-04-01

Similar Documents

Publication Publication Date Title
ES547871A0 (es) Metodo para producir la proteina factor recombinante de necrosis de tumores hermanos (tnf) a partir de celulas hospedantes competentes transformadas con un vector de expresion.
DK151985D0 (da) Humant fysiologisk aktivt polypeptid
ATE120759T1 (de) Atrielle natriumuretische/gefässerweiterende polypeptide.
DE3671244D1 (de) Fusionspolypeptid mit antigener wirkung.
DE3686397D1 (de) Kovalent gebundene polypeptid enthaltende zellmodulatoren.
ES8802159A1 (es) Un procedimiento de producir un acido desoxirribonucleico (adn)que tiene o contiene una secuencia de base que codificaun polipeptido de factor de necrosis tumoral de humano
DE3672076D1 (de) Steuern von absuchgruppen fuer mehrfachanschluesse in einem vermittlungssystem mit verteilersteuerung.
ES533925A0 (es) Procedimiento para producir un vehiculo de expresion para la formacion de uroquinasa humana
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
NO864139D0 (no) Polypeptid virksomt ved dannelse av aids-antistoff.
ES557479A0 (es) Un procedimiento para preparar una celula huesped transformada con un vector de expresion replicable
IT8122713A0 (it) Articolo isolante composito per la realizzazione di coperture prefabbricate.
AU2092983A (en) Porcine growth hormone produced by recombinant dna technology
DE3581336D1 (de) Polypeptid verwandt mit alpha-hanp.
ES2026206T3 (es) Procedimiento para mejorar la expresion de proteina de eucariota.
ES555559A0 (es) Procedimiento para preparar alfa-aminoacidos sustituidos
IT1138511B (it) Procedimento per la produzione di un concentrato spinto di fattore viii(ahf)
DE3381567D1 (de) Hestellung von rekombinanten wachstumsausloesenden faktoren.
DK110585D0 (da) Insulinforstaerkende peptider
DK215083A (da) Rekombinante plasmider til polypeptidudtrykkelse i mikrobielle vaertsceller
FI852866A0 (fi) Rekombinantfaktor viii-r.
ES508425A0 (es) "procedimiento para convertir acidos aciloxihexenoicos en-vinil-butirolactona".
IT8323951A0 (it) Procedimento per la sintesi di acido ursodesossicolico coniugato con la taurina.
IT7926363A0 (it) Perfezionamenti apportati al controllo di pezzi elettricamente non conduttivi.
DE3579831D1 (de) Mikroprogrammsteuerung.

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20011110